News & Updates

Show Multimedia Only
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025 byMike Ng

Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025
COVID-19 vaccines remain effective against severe outcomes
COVID-19 vaccines remain effective against severe outcomes
17 Oct 2025 byElvira Manzano

Even as COVID-19 severity wanes and public uptake declines, previous receipt of the 2024-2025 COVID vaccines continues to reduce emergency visits, hospital stays, and deaths among US veterans, as shown in a recent study.

COVID-19 vaccines remain effective against severe outcomes
17 Oct 2025